Malaria drug resistance publications
Antimalarial drug resistance hinders malaria control and is therefore a major public health problem. The WHO publication drug resistance in malaria describes the state of knowledge about this problem and outlines the current thinking regarding strategies to limit the advent, spread and intensification of drug-resistant malaria.
- Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria
-
Consideration of mass drug administration for the containment of artemisinin-resistant malaria in the Greater Mekong subregion
Report of a consensus meeting, 27-28 September 2010, Geneva, Switzerland -
Containment of malaria multi-drug resistance on the Cambodia-Thailand border
Report of an informal consultation, Phnom Penh, 29-30 January 2007 - Field application of in vitro assays sensitivity of human malaria parasites antimalarial drugs
- Global malaria control and elimination: report of a meeting on containment of artemisinin tolerance
- Global plan for artemisinin resistance containment (GPARC)
- Global report on antimalarial efficacy and drug resistance: 2000-2010
- Methods and techniques for assessing exposure to antimalarial drugs in clinical field studies
-
Methods and techniques for clinical trials on antimalarial drug efficacy
Genotyping to identify parasite populations - Methods for surveillance of antimalarial drug efficacy
-
Recommended genotyping procedures (RGPs) to identify parasite populations
Developed after an informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization, 29‐31 May 2007, Amsterdam, The Netherlands